Article thumbnail

The Effect of Selenium Supplementation in the Prevention of DNA Damage in White Blood Cells of Hemodialyzed Patients: A Pilot Study

By Bronislaw A. Zachara, Jolanta Gromadzinska, Jadwiga Palus, Zbigniew Zbrog, Rafal Swiech, Ewa Twardowska and Wojciech Wasowicz

Abstract

Patients with chronic kidney disease (CKD) have an increased incidence of cancer. It is well known that long periods of hemodialysis (HD) treatment are linked to DNA damage due to oxidative stress. In this study, we examined the effect of selenium (Se) supplementation to CKD patients on HD on the prevention of oxidative DNA damage in white blood cells. Blood samples were drawn from 42 CKD patients on HD (at the beginning of the study and after 1 and 3 months) and from 30 healthy controls. Twenty-two patients were supplemented with 200 μg Se (as Se-rich yeast) per day and 20 with placebo (baker's yeast) for 3 months. Se concentration in plasma and DNA damage in white blood cells expressed as the tail moment, including single-strand breaks (SSB) and oxidative bases lesion in DNA, using formamidopyrimidine glycosylase (FPG), were measured. Se concentration in patients was significantly lower than in healthy subjects (P < 0.0001) and increased significantly after 3 months of Se supplementation (P < 0.0001). Tail moment (SSB) in patients before the study was three times higher than in healthy subjects (P < 0.01). After 3 months of Se supplementation, it decreased significantly (P < 0.01) and was about 16% lower than in healthy subjects. The oxidative bases lesion in DNA (tail moment, FPG) of HD patients at the beginning of the study was significantly higher (P < 0.01) compared with controls, and 3 months after Se supplementation it was 2.6 times lower than in controls (P < 0.01). No changes in tail moment was observed in the placebo group. In conclusion, our study shows that in CKD patients on HD, DNA damage in white blood cells is higher than in healthy controls, and Se supplementation prevents the damage of DNA

Topics: Article
Publisher: Humana Press Inc
OAI identifier: oai:pubmedcentral.nih.gov:3152706
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1988). A simple technique for quantitation of low levels of DNA damage in individual cells.
  2. (1995). Albertazzi A
  3. (2003). Antioxidant nutrients and chronic disease: use of biomarkers of exposure and oxidative stress status in epidemiologic research.
  4. Arain MB et al (2008) Evaluation of toxic metals in blood and urine samples of chronic renal failure patients, before and after dialysis.
  5. (2002). Assessment of DNA strand breakage by the alkaline COMET assay in dialysis patients and the role of Vitamin E supplementation.
  6. (1977). Cancer mortality correlation studies–III: statistical associations with dietary selenium intakes.
  7. (2003). Cancer of the kidney and urinary tract on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand.
  8. (1998). Chemopreventive agents: selenium.
  9. (2007). Chemotherapeutic selectivity conferred by selenium: a role of p53-dependent DNA repair.
  10. (2009). Chronic renal failure induces genetic instability in multiple organs of Wistar rats.
  11. (2010). Chronic treatment with statins increases the availability of selenium in the antioxidant defence systems of hemodialysis patients.
  12. (2001). Comet-assay analysis identifies genomic damage in lymphocytes of uremic patients.
  13. (1993). De Meo MP et al
  14. (2004). Dietary cancer and prevention using antimutagens. Toxicology
  15. (2006). Dietary supplements of vitamins E and C and beta-carotene reduce oxidative stress in cats with renal insufficiency.
  16. (1999). DNA damage detected by the comet assay in the white blood cells of workers in a wooden furniture plant.
  17. (2001). DNA damage from micronutrient deficiencies is likely to be a major cause of cancer.
  18. (2005). DNA oxidative damage in patients with dialysis treatment.
  19. (2006). Effect of different hemodialysis regimens on genomic damage in end-stage renal failure.
  20. (2006). Free radicals, metals and antioxidants in oxidative stress-induced cancer.
  21. (2007). From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal 9:775–806
  22. HW et al (2000) 8-hydroxy-2′-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients.
  23. (2009). Investigating oxidative DNA damage and its repair using the comet assay.
  24. (2009). Investigations on the role of base excision repair and non-homologous end-joining pathways in sodium selenite-induced toxicity and mutagenicity in Saccharomyces cerevisiae.
  25. Koylu AO et al (2006) The association of circulating leptin level with peripheral DNA damage in hemodialysis subjects.
  26. (2009). Lessons from the selenium and vitamin E cancer prevention trial (SELECT).
  27. Liao JD et al (2008) Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite.
  28. (2009). Low level of methylmercury induce DNA damage in rats: protective effects of selenium.
  29. Manns et al (2009) Trace elements in hemodialysis patients: a systematic review and meta-analysis.
  30. (1990). Multivariate statistical methods (Polish edn) PWN.
  31. (2008). New approaches for the treatment of genomic damage in end-stage renal disease.
  32. (2009). Niacin ameliorates oxidative stress, inflammation, proteinuria, and hypertension in rats with chronic renal failure.
  33. (2007). Noninvasive prediction of prostatic DNA damage by oxidative stress challenge of peripheral blood lymphocytes. Cancer Epidemiol Biomark Prev 16:1906–1910
  34. (2009). Nutrition and oncogeriatry.
  35. (2001). Nutritional selenium supplements: product types, quality, and safety.
  36. (2002). Oxidative DNA damage in human white blood cells in dietary antioxidant intervention studies.
  37. (2009). Producing selenium-enriched eggs and meat to improve the selenium status of the general population.
  38. (2005). Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model.
  39. (2003). Recommendations for conducting the in vivo alkaline Comet assay.
  40. (2006). Red blood cell and plasma glutathione peroxidase activities and selenium concentration in patients with chronic kidney disease: a review.
  41. (2008). Reduction of the genomic damage level in haemodialysis patients by folic acid and vitamin B12 supplementation.
  42. (2009). Regulation and function of selenoproteins in human disease.
  43. (1993). Reversal of selenium and zinc deficiencies in chronic hemodialysis patients by intravenous sodium selenite and zinc gluconate supplementation.
  44. Roszkowski K et al (2002) Oxidative DNA damage: assessment of the role in carcinogenesis, atherosclerosis, and acquired immunodeficiency syndrome. Free Radic Biol Med 33:192–200
  45. (2001). Selenium and glutathione levels, and glutathione peroxidase activities in blood components of uremic patients on
  46. (2004). Selenium and glutathione peroxidases in blood of patients with different stages of chronic renal failure.
  47. (2009). Selenium and selenium-antagonistic elements in nutritional cancer prevention.
  48. (2009). Selenium and vitamin E supplementation for cancer prevention.
  49. (1971). Selenium distribution and human cancer mortality
  50. (2006). Selenium, selenoproteins, and cancer.
  51. (2006). Selenium: from cancer prevention to DNA damage.
  52. (2002). Selenomethionine induction of DNA repair response in human fibroblasts.
  53. (2000). Selenomethionine: a review of its nutritional significance, metabolism, and toxicity.
  54. Siomek A et al (2009) Elevated level of 8-oxo-7, 8-dihydro-2′-deoxyguanosine in leukocytes of BRCA1 mutation carriers compared to healthy controls.
  55. Siomek A et al (2009) Selenium supplementation reduced oxidative DNA damage in adnexectomized BRCA1 mutations carriers. Cancer Epidemiol Biomark Prev 8:2923–2928
  56. Sung YJetal(2000)EffectofvitaminE-bondedmembraneonthe 8-hydroxy 2′-deoxyguanosine level in leukocyte DNA of hemodialysis patients.
  57. (2004). The comet assay for DNA damage and repair. Principles, applications and limitations.
  58. (1997). The comet assay: what can it really tell us?
  59. (2009). The human selenoproteome: recent insights into functions and regulation. Cell Mol Life Sci 66:2457–2478 282 Zachara et al.53. Valdiglesias V, Pasaro E,
  60. (2003). The interacting pathways for prevention and repair of oxidative DNA damage.
  61. (2003). The nutritional significance, metabolism and toxicology of selenomethionine.
  62. (2010). The organic selenium compound selenomethionine modulates bleomycin-induced DNA and repair in human leukocytes.
  63. (2006). The role of antioxidant supplementation in occupational exposure to waste anaesthetic gases. Int Arch Occup Environ Health 80:154–159
  64. Torregrosa Maicas I, Tormos Munoz M et al (2009) Study of oxidative stress in advanced kidney disease.
  65. (2008). Toxicity and mutagenicity of selenium compounds in Saccharomyces cerevisiae.
  66. (2010). Trace element status in hemodialysis patients.